Metabolites are critical signaling molecules that mediate host-microbiome communication and dynamics. Microbial bioactive metabolites produced by the gut microbiota have been implicated in numerous human health conditions including obesity, insulin resistance, cardiovascular disease, autism-spectrum disorder and Parkinson’s disease. In addition to providing fundamental insights into disease pathology, these molecules may offer avenues to therapeutic strategies and biomarker discovery. Consequently, attention in the microbiome field is increasingly turning to metabolomics – the discipline of measuring metabolites in a comprehensive and non-targeted manner – as a powerful tool to elucidate how the gut microbiome exerts its effects on human health and disease.
Join us for our upcoming Lunch & Learn session titled “Applications of Metabolomics in Microbiome Research” on Wednesday February the 2nd, 2022, at 12 PM to learn more!
Case Studies:
- Modulating the Gut Microbiome: The Biotechnological and Therapeutic Value of Bacteriophages.
- Mechanistic Insights: Microbiota and Autism, from Discovery to Clinical Utility.
The 15-20 minute case studies session shall be followed by a 15 minute Q&A session.
We are looking forward to seeing and engaging with you.
Recent Comments